This video Presentation was recorded at the Brain Tumour National Conference in Toronto, Ontario on Saturday, October 20th, 2018 with Dr. Lynda Balneaves.
In this session, a review of the latest evidence regarding the benefits and risks of medical cannabis and its role in the management of brain tumours will be provided. Current legislation regarding cannabis use in Canada, as well as harm reduction strategies will also be discussed to support patients and family members in making informed decisions about cannabis.
1. Identify the benefits and risks of medical cannabis in the context of brain tumours.
2. Understand the current legislation regarding cannabis use in Canada.
3. Discuss harm reduction strategies related to cannabis use.
Learn more about the National Conference:
Connect with Brain Tumour Foundation of Canada:
Call Toll Free 1-800-265-5106 or locally 519-642-7755 – call with any questions and connect today!
Brain Tumour Foundation of Canada
205 Horton St E, Suite 203,
London, ON N6B 1K7
Charitable Registration #BN118816339RR0001
Copyright of all videos created by Brain Tumour Foundation of Canada on this website, including the underlying HTML, text, illustrations, designs, icons, audio clips, video clips, documents, products, software and all other content is either owned by the Brain Tumour Foundation of Canada, or Brain Tumour Foundation of Canada has obtained a license to use the materials.
The videos on the site are protected by the Copyright Act. None of the videos may be copied, reproduced, distributed, republished, downloaded, or transmitted in any form or by any means, without the prior written consent of Brain Tumour Foundation of Canada, or the original creator, where applicable.
All information within the videos has been posted to provide Canadians affected by a brain tumour with support, education, information and an understanding of research programs or to thank donors and supporters for their contributions. The information has been posted with the intent that it be readily available for personal and public non-commercial (educational) use. The allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.